These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


275 related items for PubMed ID: 16972887

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. MIB-1 labeling index in astrocytic tumors--a clinicopathologic study.
    Neder L, Colli BO, Machado HR, Carlotti CG, Santos AC, Chimelli L.
    Clin Neuropathol; 2004; 23(6):262-70. PubMed ID: 15584210
    [Abstract] [Full Text] [Related]

  • 4. Microvessel density in brain tumors.
    Assimakopoulou M, Sotiropoulou-Bonikou G, Maraziotis T, Papadakis N, Varakis I.
    Anticancer Res; 1997; 17(6D):4747-53. PubMed ID: 9494601
    [Abstract] [Full Text] [Related]

  • 5. Secreted protein, acidic and rich in cysteine (SPARC) expression in astrocytic tumour cells negatively correlates with proliferation, while vascular SPARC expression is associated with patient survival.
    Capper D, Mittelbronn M, Goeppert B, Meyermann R, Schittenhelm J.
    Neuropathol Appl Neurobiol; 2010 Apr; 36(3):183-97. PubMed ID: 20132490
    [Abstract] [Full Text] [Related]

  • 6. Tenascin-C expression relates to clinicopathological features in pilocytic and diffuse astrocytomas.
    Maris C, Rorive S, Sandras F, D'Haene N, Sadeghi N, Bièche I, Vidaud M, Decaestecker C, Salmon I.
    Neuropathol Appl Neurobiol; 2008 Jun; 34(3):316-29. PubMed ID: 17983425
    [Abstract] [Full Text] [Related]

  • 7. Tumour vasculature and angiogenic profile of paediatric pilocytic astrocytoma; is it much different from glioblastoma?
    Sie M, de Bont ES, Scherpen FJ, Hoving EW, den Dunnen WF.
    Neuropathol Appl Neurobiol; 2010 Dec; 36(7):636-47. PubMed ID: 20704656
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Characteristics of tumour vessels in cytological squash smears of astrocytic tumours.
    Sato S, Sato Y, Marutsuka K, Takeshima H, Asada Y.
    Cytopathology; 2011 Oct; 22(5):313-7. PubMed ID: 21039979
    [Abstract] [Full Text] [Related]

  • 10. Prognostic significance of IL-8-STAT-3 pathway in astrocytomas: correlation with IL-6, VEGF and microvessel morphometry.
    Piperi C, Samaras V, Levidou G, Kavantzas N, Boviatsis E, Petraki K, Grivas A, Barbatis C, Varsos V, Patsouris E, Korkolopoulou P.
    Cytokine; 2011 Sep; 55(3):387-95. PubMed ID: 21684758
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Tumour vascularity is a significant prognostic factor for cervix carcinoma treated with radiotherapy: independence from tumour radiosensitivity.
    Cooper RA, West CM, Wilks DP, Logue JP, Davidson SE, Roberts SA, Hunter RD.
    Br J Cancer; 1999 Sep; 81(2):354-8. PubMed ID: 10496365
    [Abstract] [Full Text] [Related]

  • 13. Quantification of angiogenesis by the Chalkley method and its prognostic significance in epithelial ovarian cancer.
    Suhonen KA, Anttila MA, Sillanpää SM, Hämäläinen KM, Saarikoski SV, Juhola M, Kosma VM.
    Eur J Cancer; 2007 May; 43(8):1300-7. PubMed ID: 17448653
    [Abstract] [Full Text] [Related]

  • 14. Clinical significance of sphingosine kinase-1 expression in human astrocytomas progression and overall patient survival.
    Li J, Guan HY, Gong LY, Song LB, Zhang N, Wu J, Yuan J, Zheng YJ, Huang ZS, Li M.
    Clin Cancer Res; 2008 Nov 01; 14(21):6996-7003. PubMed ID: 18980995
    [Abstract] [Full Text] [Related]

  • 15. Intra-operative characterization of gliomas by near-infrared spectroscopy: possible association with prognosis.
    Asgari S, Röhrborn HJ, Engelhorn T, Stolke D.
    Acta Neurochir (Wien); 2003 Jun 01; 145(6):453-59; discussion 459-60. PubMed ID: 12836069
    [Abstract] [Full Text] [Related]

  • 16. Prognostic significance of flow cytometry deoxyribonucleic acid analysis of human astrocytomas.
    Coons SW, Johnson PC, Pearl DK.
    Neurosurgery; 1994 Jul 01; 35(1):119-25; discussion 125-6. PubMed ID: 7936132
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Assessment and prognostic significance of mitotic index using the mitosis marker phospho-histone H3 in low and intermediate-grade infiltrating astrocytomas.
    Colman H, Giannini C, Huang L, Gonzalez J, Hess K, Bruner J, Fuller G, Langford L, Pelloski C, Aaron J, Burger P, Aldape K.
    Am J Surg Pathol; 2006 May 01; 30(5):657-64. PubMed ID: 16699322
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. p53-mediated inhibition of angiogenesis in diffuse low-grade astrocytomas.
    Gaiser T, Becker MR, Meyer J, Habel A, Siegelin MD.
    Neurochem Int; 2009 Jun 01; 54(7):458-63. PubMed ID: 19428789
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.